surg medias tin um spn lungca
Post on 06-Apr-2018
221 Views
Preview:
TRANSCRIPT
8/3/2019 Surg Medias Tin Um Spn Lungca
http://slidepdf.com/reader/full/surg-medias-tin-um-spn-lungca 1/14
1
The Mediastinum
- Anatomic space that lies between two pleural cavities and extends from the diaphragm to the
thoracic inlet.
Subdivisions of the Mediastinumas seen in cross section
•anterior mediastinum (1)•middle mediastinum (2)
•posterior mediastinum (3)
A lot of lymph nodes can be found in the mediastinal compartments = a common neoplasm:LYMPHOMA because of lymphatic spread.
I. Anatomya. Borders
Thoracic Inlet – Superior Diaphragm – InferiorlySternum – AnteriorlyVertebral Column – Posteriorly
b. 3 Compartments and Contents:
Compartment Contents
Anterosuperior Thymus gland, lymph nodes, fat, aortic arch, superior vena cava, parathyroid gland, ectopic thyroid tissue
Middle Pericardium, heart, great vessels, trachea, and trachealbifurcation, main bronchi, phrenic nerves, hilar lymph node
Posterior Esophagus, vagus nerves, sympathetic chain, thoracicduct, descending thoracic aorta, azygous vein,
hemiazygous vein, paravertebral lymph node
sometimes the thyroid grows too big due to anomalies, so big that it goes into the neck or into themediastinum.
Topic: Mediastinum, Solitary Pulmonary Nodule, Lung CA
Lecturer: Dr. Gervasio
8/3/2019 Surg Medias Tin Um Spn Lungca
http://slidepdf.com/reader/full/surg-medias-tin-um-spn-lungca 2/14
2
II. Diagnostica. Chest X-rays – mediastinal masses commonly found incidentallyb. CT Scan – second most common modality used, next to x-ray
c. Magnetic Resonance Imaging – useful for better visualization of certain vascular structures
d. CT Guided Needle Biopsy (FNAB vs Core)e. Mediastinoscopy with biopsy – cytopathologists needed to read FNAB better
• Mediastinoscopy is a surgical procedure to examine the inside of theupper chest between and in front of the lungs (mediastinum).
f. VATS (Video-Assisted Thorascopic Surgery) • is a minimally invasive surgical technique used to diagnose and treat problems in the
chest. During this surgery, one or more small incisions are made in the chest. A tiny
fiber-optic camera (called a thorascope) is inserted through one incision, and surgical instruments are inserted through this or other small incisions. The thoracoscopetransmits images inside the chest on a video monitor, guiding the surgeon inmaneuvering instruments to complete the procedure (sounds a lot like laparascopic surgery right?)
g. Radionuclide Scanning – a way of imaging bones, organs and other parts of the body by
using a small dose of a radioactive chemical.h. Angiography
i. Immunologic Staining – this is done since it may be difficult to distinguish one mediastinaltumor from the other
It is important to know the normal first, before you can understand the abnormal.Below is a normal CXR shown with labels.
absent clavicle on the left side note gas bubble of left side; dextrocardia
8/3/2019 Surg Medias Tin Um Spn Lungca
http://slidepdf.com/reader/full/surg-medias-tin-um-spn-lungca 3/14
3
III. Mediastinal Tumors and CystsIn Adults
o 25-35% malignant;o Neurogenic tumors most common @ 20%o Thymomas (most common anterior mediastinal tumor in adults), congenital cysts,
lymphomas (most common in both adults and children but more common in children?Which one is it doc? =/ )
o Usually asymptomaticIn Childreno 25-45% malignanto Lymphomas (most common), neurogenic tumor
Symptomatology:
1/3 to half of the cases are asymptomatic Non-specifc symptoms include chest pain, cough, dyspnea (Compression Syndrome) Endocrine Symptoms:
o Hypertension – Pheochromocytomao Hypercalcemia – Parathyroid tumor o Thyrotoxicosis – Intrathoracic goiter o Gynecomastia – Choriocarcinoma
I. Thymoma
Most common anterior mediastinal mass in adult• Rare in children
1/3 are asymptomatic at diagnosis Symptoms include: mass effects (compression symptoms) and systemic
effects due to paraneoplastic syndromes (Myasthenia gravis)• Myasthenia gravis is seen in 10-50% of patients with thymomas• Thymomas is seen in only 8-15% of patients with Myasthenia gravis
Histopathology: proportion of lymphocytes to epithelial cells Malignancy = Invasiveness (capsular or vascular) Treatment: Surgery + radio and chemotherapy
II. Germ Cell Tumor Primary extra-gonadal germ cell tumors are RARE!
• Only 1% of all mediastinal tumors. Most common in the anterior mediastinum
M>F predilection (4:1) Commonly affects young adults Types:
• Seminoma• Embryonal cell carcinoma• Choriocarcinoma• Malignant Teratoma• Endodermal yolk sac tumor
Diagnosis: CT Scan and Tumor Markers (B-HCG, A-fetoprotein,
Carcinoembryonic antigen or CEA) Treatment: Complete Resection and Adjuvant Therapy
• Seminomas – radiosensitive = better prognosis• Other tumors – chemotherapy
III. Lymphomas Mediastinal involvement seen in 50% of both Hodgkin’s and non-Hodgkin’s
lymphoma
Most common mediastinal malignancy Most commonly seen in the anterior mediastinum Symptoms include: cough, chest pain, fever and weight loss Diagnosis:
• Chest X-ray and CT Scan• Mediastinotomy/mediastinoscopy with biopsy
Sometimes immunohistopathology is done if pathologists can’t figure it out!
Treatment:• Radiotherapy and Chemotherapy• Surgery – done mainly for diagnosis
Resection is NOT done for lymphomas
IV. Teratomas Mostly in adolescents 80-85% of cases are benign Contains all 3 germ layers: endoderm, mesoderm, and ectoderm Many are asymptomatic; others have symptoms related to compression
(cough, pleuritic chest pains, dyspnea) Diagnosis: X-ray and CT Scan (smooth walled cystic or solid lesions) Treatment: Total Surgical Excision
8/3/2019 Surg Medias Tin Um Spn Lungca
http://slidepdf.com/reader/full/surg-medias-tin-um-spn-lungca 4/14
4
Middle Mediastinal Lesionso usually cystic o 2 most common lesions:
Pericardial Cyst• Usually asymptomatic
• Found on chest x-ray at cardiophrenic angle• Surgery is both diagnostic and therapeutic
Bronchogenic Cyst• Arise posterior to the carina• May be asymptomatic or may cause compression symptoms• Treated by excision
Patients often complain of compression symptoms
(+) lining of the cyst on CXR – differentiates it frompneumothorax
Posterior Mediastinal Lesionso mostly neurogenic lesions along the paravertebral gutter o 25% are malignanto 75% of cases occur in children (<4 years old)
Higher probability of malignancy
Surgery may not be an option in most malignant cases
Dumbbell tumors – tumors that grow inside the spinal canal with another extension outside; surgically a cause for concern; may cause rapid bleeding death
More diagnostic tools are implicated to study the spinal canal
o Common histologic types:Neurilemomas Neurofibromas Neurosarcomas Ganglioneuromas Neuroblastomas Pheochromocytoma
– from Schwanncells; slowgrowing; well
circumscribedand have adefined capsule
– has malignantpotential; poorlyencapsulated
and consists of randomlyarranged
spindle-shapedcells
– originate bymalignantdegeneration of
either neurilemomas or neurofibromas, in
addition todeveloping denovo; usually
occurs in adults
– from sympatheticganglia; wellencapsulated
– also fromsympathetic chain;highly invasive
(have alreadymetastasize beforediagnosis)
Rarely occurs;behave similarly toadrenal lesions
o Symptoms: Chest pain Spinal cord compression Endocrine symptoms Fever, vomiting, diarrhea and cough in Neuroblastoma
o Treatment: Surgery and Radiotherapy (for malignant lesions) In the recording doc said chemo and radiotherapy??
Superior Vena Cava Syndromeo 85% of cases are due to Bronchogenic CA (most commonly small cell type – 40%)
o Causes:• Mediastinal tumors• Fibrosing mediastinitis• Thoracic aortic aneurysm• SVC thrombosis due to catherization/instrumentation
o Presents as venous distention, facial edema, plethora, headache, and respiratorysymptoms
o Diagnosis: CT Scan
o Treatment:• Radiation and Chemotherapy (palliative)• Steroids and Diuretics – still questionable• Bypass or Vein Reconstruction (for benign lesions)• Stenting: Endovascular Procedure
IV. Mediastinal InfectionsAcute Mediastinitis
fulminant infection with high morbidity and mortality Rapid spread through areolar planes, within 24 hours, to involve neck andlungs Both gram (+) and (-) bacteria Symptoms: chest pain, dysphagia, respiratory distress, subcutaneous
crepitation Diagnosis: Chest X-ray, Water soluble contrast study Treatment: hydration, drainage, control of primary problem (must be early and
aggressive) **antibiotics are also given Etiology: Esophageal or tracheal perforations
• Open heart surgery – more indolent course; usually due toStaphylococcus (MRSA)
Esophageal perforation – a very real complication; rare in trauma; more commonly injured in endoscopicprocedures or intentional intake of corrosive substances (acid ingestion is common in the phils)
Chronic Mediastinitis Chronic fibrosis and inflammation Usually due to granulomatous infections (TB, Histoplasmosis)
8/3/2019 Surg Medias Tin Um Spn Lungca
http://slidepdf.com/reader/full/surg-medias-tin-um-spn-lungca 5/14
5
SOLITARY PULMONARY NODULE
—SPN: 3 cm or less in diameter About 40% malignant—Lung mass: greater than 3 cm Vast majority are malignant
size = risk of it being malignant it is important to rule out malignancy!
Differential Diagnosis of SPN—Neoplasm—Infection (commonly TB)—Inflammation—Vascular —Trauma—Congenital—Rheumatoid nodule—Lymph node—Sarcoidosis
by examining the CXR, one can have an idea if it is malignant or being consider px risk factors, medical Hx
Factors Influencing Probability of Malignancy
—Size—Growth rate 25% in diameter = doubling of the volume
more malignant = shorter doubling time don’t rely on just one radiologic examination, usually a series of radiographs must be reviewed to compare the
size of the tumor seen in older films
—Number —Density—Circumstances of CT—Patient age—Gender —Smoking history—Spirometry—Occupational history—Endemic granulomatous disease
Size of SPN—Most SPN are less than 2 cm in diameter —Malignant nodules
—40% less than 2 cm—15% less than 1 cm
—1% less than 7 mm—0% less than 5 mm
Growth Rate: Doubling Time—Volume = 4/3 Π r
3
—25% increase in diameter results in doubling of volume
—Non-malignant disease: less than 20 days or greater than 400 days—Malignant lesions: 30 to 180 days
note: germ cell tumors, melanomas, sarcoma can grow in 2 weeks classically; thyroid can take months
Radiographic Characteristics
Malignant disease Benign disease
—Spiculated (primary) 90% malignant—Round, smooth, and peripheral(metastatic) 20% malignant—Thick walled cavity—Eccentric calcification
—Characteristic calcifications—Smaller than 5 mm—Non-solid lesion 5-9 mm—Thin walled cavity—Satellite nodules**no growth in the last 2 yrs? Probably benign
Note: Eccentric calcifications can occur in malignancies, especially at scar sites, so called scar carcinomas
8/3/2019 Surg Medias Tin Um Spn Lungca
http://slidepdf.com/reader/full/surg-medias-tin-um-spn-lungca 6/14
6
SPN: RUL
SPN: RUL: Spiculated lesion Malignancy, Right upper lobe, posterior segmentTB almost never affects
anterior segment
SPN: Lesion behind rib One of the reasons theydo the Apico-lordoticview
SPN: Posterior lesion Primary lung cancer, RUL,posterior segment
Popcorn calcification
Central calcification
8/3/2019 Surg Medias Tin Um Spn Lungca
http://slidepdf.com/reader/full/surg-medias-tin-um-spn-lungca 7/14
7
WORK-UP OF SPNMultidisciplinary Approach—PCP—Radiology
—Pulmonary—Thoracic surgery
—Oncology—Review prior films!
Others:Advanced directivesStratification of careInformation regarding possible outcomesPt advocate and shepard
Imaging and Procedures—CXR
—CT Scan—CT Scan with contrast to evaluate mediastinum
—Serial scans at 3, 6, 12, and 24 months
—Can consider trial of antibiotics prior to repeat scan in 6 weeks —Newer CT techniques
—Volumetric analysis—Multi-slice scanner
—PET Scan—Positron Emission Tomography—18-FDG (fluorodeoxyglucose)
—increased uptake by metabolically active cells (like tumor cells, but not exclusively…socorrelate clinically)—does not enter glycolysis—Allows more accurate identification of tumors, lymph nodes, and metastatic disease
Benign disease Malignant disease 96% sensitivity 96% sensitivity88% specificity 77% specificity
Note: Can more clearly determine if a lesion is malignant; Can detect LN mets and
unsuspected metastatic disease
Limitations of PET Scans—Spatial resolution 7-8 mm thus unreliable for lesions less than 1 cm—False positives in infection or inflammation—False negatives in tumors with low uptake such as bronchoalveolar cell carcinoma—High post test likelihood of malignancy (14%) in high risk patients with negative PET
Utilization of PET Scans
—Negative PET in high risk patients still need tissue diagnosis…so why get it?—PET not usually indicated unless it will change management—PET not indicated if surgery is planned—PET not indicated with known malignancy
—Bronchoscopy—Limited role—Transbronchial needle aspiration of mediastinal lymph node—Useful for large central lesions and endobronchial lesions—Can detect infection—No use in peripheral nodules
—Biopsy—CT guided—Transthoracic needle aspiration (TTNA)
—Increasing utilization of TTNA—Not indicated for patients committed to surgery—Accuracy for detecting malignancy 64-100%—Yield increased when cytopathologist present
—Three results:—Malignant
—Specific benign, e.g. TB—Non-specific benign, e.g. bronchoalveolar hyperplasia—Complications:
—Pneumothorax 25%, chest tube <5%, Hemoptysis <10%—Relative contraindications:
—Pulmonary HTN, severe COPD, AVM’s, coagulopathy—Absolute contraindication:
—One lung or bilateral lung transplant—Fine needle aspiration (FNA)
—Surgical —Video Assisted Thoracic Surgery (VATS)
—peripheral nodules within 2 cm of pleura
—for solid lesions; superficial lesions (lung surface)—for lesions not diagnosed by other means
—Open Thoracotomy—commitment to resection with curative intent; if lesion is not locatedsuperficially
—No change in two years - no further
evaluation—Characteristic calcifications of benign
disease
—Lateral films for “hidden” lesions
—Initial CXR then serial CT Scans
8/3/2019 Surg Medias Tin Um Spn Lungca
http://slidepdf.com/reader/full/surg-medias-tin-um-spn-lungca 8/14
8
Pulmonary Specific Preoperative Evaluation Prior to Lung Resection—PFT’s are predictive of post-op complications and mortality—DLCO correlates with risk of post-op mortality better than FEV1—PaCO2 > 45 not an independent risk factor
—Three stages:—PFT’s
—Quantitative Lung Scan—Exercise Testing
Stage I Assessment: PFT’sPredictors of Low
Complication Rates
Stage II Assessment:Quantitative V/Q Scan
Stage III Assessment:Exercise Testing
—No further work-up and nolimitations:—FEV1 > 2 L andDLCO > 60% predicted
—Pneumonectomy:—FEV1 > 2L and DLCO > 60% predicted
—Lobectomy:—FEV1 > 1L and
DLCO > 50% predicted
—Wedge / Segmentectomy:—FEV1 > 0.6 L and DLCO > 50%predicted
—Patients who do not meetStage I criteria
—Ventilation:133
Xe—Perfusion:
99Tc labeled
macroaggregates
—Radioactive uptake correlates
with lung function
—Post-op FEV1 = (pre-opFEV1) x (% of radioactiveuptake of non-operated lung)
—Pneumonectomy:—ppo FEV1 > 40% of
predicted
—ppo DLCO > 40% of predicted
—Cardio-pulmonary exercisetesting (CPET)
—VO2 > 20 ml/kg/min…acceptable risk
—VO2 < 15ml/kg/min…increased risk
—VO2 > 20 ml/kg/mincorrelates with 5 flights
—Stair Climbing—3 flights: FEV1 > 1.7 L
—5 flights: FEV1 > 2 L
Exceptions to the RulesCHEST 2005; 127:1984-1990
Foundation of Algorithms—No change in 24 months on CXR or CT requires no further evaluation—Serial CT Scans at 3, 6, 12, and 24 months
—TTNA for those not committed to surgery—Surgical biopsy with curative intent—Pre-op evaluation prior to surgery
8/3/2019 Surg Medias Tin Um Spn Lungca
http://slidepdf.com/reader/full/surg-medias-tin-um-spn-lungca 9/14
9
Sample Pre-biopsy AlgorithmCHEST 2004; 125:1522-1529
Sample Post-biopsy AlgorithmCHEST 2004; 125:1522-1529
8/3/2019 Surg Medias Tin Um Spn Lungca
http://slidepdf.com/reader/full/surg-medias-tin-um-spn-lungca 10/14
10
Sample Preoperative Evaluation AlgorithmCHEST 2003; 123:2096-2103
Cases
—Case I: 20 yo female, family history of TB, non-smoker, with calcified 1 cm nodule in posterior segmentof RUL – also seen in x-ray 6 months ago —Work-up: Observation and serial imaging if indicated (because risk for lung CA is)
—Case II: 60 yo male history of O2 dependent COPD, remote colon cancer, 40+ pk yr smoker , with 2.5cm irregular nodule in anterior segment of RUL
—Work-up: Tissue diagnosisBiopsy with curative intentPreoperative evaluation with PFT’s, DLCO, andquantitative lung scan if indicatedTTNA if surgery not an option (because risk of malignancy is )
Summary—SPN by definition is 3 cm or less
—40% are malignant—NSCLC 5-year survival
—Stage I 60%—Stage IV 1%
—Doubling times of cancer can be 30 days—REVIEW PRIOR FILMS!!!—No change in 2 years…no further work-up—Serial CT Scans at 3, 6, 12, and 24 months—TTNA for those not committed to surgery—Surgical biopsy with curative intent—Pre-op evaluation prior to surgery—PFT’s, Quantitative Lung Scan, CPET
LUNG CANCER
BRONCHOGENIC CARCINOMA Leading cause of cancer death 40 years old and above (>95%) Etiology:
Smoking – implicated in 75% or moreat least 20 pack-yearsimpact of second-hand smoke
AsbestosPetroleum productsRadioactive materials
(Role of Genetics ) - oncogenes
- there is a 20 year lag between smoking & lung
CA
- cessation of smoking = risk of developinglung CA compared to those who continue
smoking, however, risk is still compared to
never-smokers
8/3/2019 Surg Medias Tin Um Spn Lungca
http://slidepdf.com/reader/full/surg-medias-tin-um-spn-lungca 11/14
11
PRIMARY LUNG CANCER: CLASSIFICATION
Non-small cell CA Small cell / oat cell
Squamous / EpidermoidAdenocarcinoma
Scar carcinoma
Bronchoalveolar cell CA (variant)AdenosquamousLarge cell anaplastic / undifferentiated
overall 5 yr survival < 15%
50% mets at diagnosis surgery an option up to 70% 5 yr survival for Stage IA
overall <10% 5 yr survival
70% mets at diagnosis surgery not an option usually more aggressive
more proximal near tracheobronchial tree
more common associated with smoking
develops more in the periphery incidence number of female cases can also be attributed to previous injury to
the lung PTB is a possible risk factor (fibrosis) Metastasis is not uncommon
Undifferentiated CA
Tend to rapidly evolve and spread Tx: surgery Can grow anywhere, but usually centrally
located
Aggressive type of tumor Very poor prognosis Tx: non-surgical
Usually diagnosed late Generally responsive to chemotherapy,
but because patients are diagnosed late =advanced disease = poor prognosis
BRONCHOGENIC CA: DIAGNOSIS Chest x-ray
- Since the chest is a 3D structure, it is useful to get CXR
- Request for upright PA (postero-anterior) view
- Also request for the lateral upright CXR- Can detect ≥1cm nodules Sputum cytologyMay still be of some use in certain cancersBut most useful for infectious diseases
Bronchoscopy- helps assess the resectability of the tumor
CT + percutaneous needle biopsy = most useful- to obtain cytologic specimens (washing / brushing / biopsy)
- to assess bronchial/carinal involvement (assess resectability)
8/3/2019 Surg Medias Tin Um Spn Lungca
http://slidepdf.com/reader/full/surg-medias-tin-um-spn-lungca 12/14
12
Percutaneous needle biopsy CT Scan
- to assess tumor location, size, extension (useful for staging, but biopsy is still needed to come up withactual Dx of CA- to assess mediastinal lymph node status (problem: inflammatory vs neoplastic)
- with biopsy, to get histologic diagnosis Mediastinoscopy / mediastinotomy
Thoracotomy- frozen section – rapid histopathology
- not routinely done
CLINICAL MANIFESTATIONS May be asymptomatic; seen only on chest x-ray Often in advanced stages when symptomatic, and on diagnosis
Pulmonary symptoms: Extrapulmonary symptoms
cough fever dyspnea chest pain sputum production
- related to site of metastasis- may be secondary to hormone-like
substance produced by the tumor (e.g. Small cell CA Cushing’sSyndrome)
PANCOAST TUMOR Superior pulmonary sulcus tumor Different from apical lung carcinoma Symptoms may be due to:
Brachial plexus involvementSympathetic ganglia involvement
Vertebral body involvement / collapseHorner’s syndrome
ptosis miosis anhydrosis enophthalmos
BROCHOGENIC CA: STAGING
Based on the TNM ClassificationT – tumor size, location, extentN – regional lymph node involvementM – distant metastasis
Considers Host Performance StatusHo (normal activity) H4 (bedridden)
Categories: c - clinicals - surgicalp – postsurgical / pathologicr – retreatmenta - autopsy
**paralysis of the hemodiaphragm – consider possible involvement of the phrenic nerve
**hourseness – consider involvement of the laryngeal nerve**each lung lobe has its own arterial supply, drainage, etc – each can function independently**lobectomy is usually done (lobectomy)
**a px can even tolerate removal of one whole lung (Pneumonectomy)
BRONCHOGENIC CA: TREATMENT- Surgery – for early lesions ( up to IIIA )
Lobectomy usually minimum resectionPneumonectomy or variant at times
- Radiotherapy - as adjuvant / palliative tx; usually given after surgery of if surgery is not possible- Chemotherapy – as neoadjuvant / adjuvant / palliative tx- Immunotherapy – still being developed
**after surgical resection body compensates lungs tend to hyperinflate**if a whole lung is removed replaced with fluid solidification fibrosis
BRONCHOGENIC CA: CONTRAINDICATIONS TO SURGERY Malignant pleural effusion Recurrent laryngeal nerve involvement (manifests with hoarseness, but also rule out laryngitis
before considering matastasis) Distant metastasis Contralateral mediastinal LN involvement Carinal / high paratracheal LN involvement Scalene or supraclavicular LN involvement
Tumor invasion of the heart, great vessels, esophagus, trachea, vertebral body Superior vena cava syndrome (secondary to compression by the tumor) Phrenic nerve paralysis Poor pulmonary function (relative contraindication; in line with this…some surgeons would still do a
segmentectomy (less than a lobectomy) just to reduce the tumor load in order to improve thepulmonary function)
8/3/2019 Surg Medias Tin Um Spn Lungca
http://slidepdf.com/reader/full/surg-medias-tin-um-spn-lungca 13/14
13
**sometimes a tumor might obstruct the airway, usually the primary and secondary bronchi. So if possible,laser ablation is done to re-establish the airway. A stent is sometimes inserted just to open up the airway
PALLIATIVE TREATMENT Surgery – USUALLY NOT ADVOCATED Radiotherapy / Chemotherapy
Bronchoscopic obliteration of tumor by laser – for bronchial obstruction
PROGNOSISDepends on: Cell type and differentiation
Stage at the time of diagosisVarious host factors
NSCLC Survival Rates›Stage I 60%›Stage II 23%
›Stage IIIA 11% surgery›Stage IIIB 5% no surgery›Stage IV 1%
**Distinction between IIIA and IIIB is key due to surgical intervention**Malignant effusion is IIIB, surgery not indicated, therefore tap the effusion
Small Cell Lung Cancer **Surgery rare and limited to very small localized early disease**Brain mets occur in 10% at diagnosis**Paraneoplastic syndromes….SIADH, Eaton Lambert,
›Limited (30-40%) ›Extensive (60-70%)
›confined to one hemithorax›one RT portal›chemo and RT›median survival: 18 mo›5 yr survival: < 18%
›not limited›cannot fit in one RT portal›chemo, palliative RT›median survival: 7 mo›5 yr survival: < 2%
8/3/2019 Surg Medias Tin Um Spn Lungca
http://slidepdf.com/reader/full/surg-medias-tin-um-spn-lungca 14/14
14
METASTATIC LUNG CANCER Fairly common May be the only site of metastasis from a nonpulmonary tumor Spread to lungs is by direct infiltration, lymphatics, blood (more important route)
SURGICAL TREATMENT: PRINCIPLESSingle or multiple metastatic tumors, even when in both lungs, CAN be removed as part of treatment
(usually the sarcomas) as long as you can:- preserve as much normal lung- have adequate margins of resection
Exclusion of other metastatic sites is important
The primary site must be controlled
Other modalities of treatment not effective
END OF TRANSCRIPTION
Hi homer leelee baggie rencie markie jemelee =)
top related